Analyst Reco. 10x Genomics, Inc.

Equities

TXG

US88025U1097

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
27.59 ^USD	+2.57%		-1.25%	-50.70%

04-18	Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating	MT
03-26	10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating	04-18	MT
UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating	02-21	MT
Stifel Cuts Price Target on 10x Genomics to $63 From $68, Maintains Buy Rating	02-16	MT
Barclays Adjusts Price Target on 10x Genomics to $55 From $45, Maintains Overweight Rating	01-25	MT
Wolfe Research Initiates 10x Genomics With Outperform Rating With $55 Price Target	12-13	MT
BofA Securities Upgrades 10x Genomics to Neutral From Underperform, Adjusts Price Target to $54 From $36	12-12	MT
UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating	11-07	MT
Barclays Lowers Price Target on 10x Genomics to $47 From $66, Maintains Overweight Rating	29/09/23	MT
Citigroup Adjusts Price Target on 10x Genomics to $75 From $65, Maintains Buy Rating	04/08/23	MT
UBS Adjusts Price Target on 10x Genomics to $62 From $58, Maintains Neutral Rating	04/08/23	MT
Deutsche Bank Adjusts 10x Genomics Price Target to $65 From $56, Maintains Buy Rating	02/08/23	MT
Goldman Sachs Adjusts Price Target on 10x Genomics to $30 From $25, Maintains Sell Rating	13/07/23	MT
Barclays Initiates 10x Genomics at Overweight With $65 Price Target	10/05/23	MT
Stifel Nicolaus Adjusts 10x Genomics Price Target to $68 From $57, Maintains Buy Rating	04/05/23	MT
TD Cowen Adjusts Price Target on 10x Genomics to $66 From $62, Maintains Outperform Rating	04/05/23	MT
UBS Adjusts 10x Genomics Price Target to $58 From $54, Maintains Neutral Rating	04/05/23	MT
UBS Raises Price Target on 10x Genomics to $54 From $50, Keeps Neutral Rating	10/04/23	MT
Stephens Starts 10x Genomics at Overweight With $65 Price Target	31/03/23	MT
Morgan Stanley Raises 10x Genomics' Price Target to $65 From $64, Maintains Overweight Rating	16/02/23	MT
Deutsche Bank Adjusts 10x Genomics Price Target to $56 From $50, Maintains Buy Rating	16/02/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. 10x Genomics, Inc.

Equities

TXG

US88025U1097

Analyst Reco.

Filters